Female Culture Device; Male Culture Device; Transfer Device; Access Device
Zhejiang Kindly Medical Device Co., Ltd. · Decision date Jun 2, 2026
What did the FDA decide?
FDA records K252899 as a 510(k) premarket notification, with a decision dated Jun 2, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Jun 2, 2026
Regulatory record facts
- Identifier
- K252899
- Regulatory pathway
- 510(k) premarket notification
- Product code
- JKA
- Decision code
- SESE
- Decision date
- Jun 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tubes, Vials, Systems, Serum Separators, Blood Collection.
- Product code
- JKA
- FDA device class
- 2
FDA decision timeline
K252899 received
Application receipt date recorded by FDA.
K252899 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JKA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| CMT Health PTE., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Sol-Millennium Medical, Inc. | 510(k) clearance | Oct 21, 2026 | FDA | |
| Becton Dickinson and Company | 510(k) clearance | Oct 16, 2026 | FDA | |
| CMT Health PTE., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA | |
| Becton Dickinson and Company | 510(k) clearance | Apr 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zhejiang Kindly Medical Device Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Wenzhou
Sources and methodology
- Original FDA record: K252899
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



